Leerink Partnrs Comments on Henry Schein Q1 Earnings

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for Henry Schein in a research report issued on Monday, October 14th. Leerink Partnrs analyst M. Cherny forecasts that the company will post earnings of $1.20 per share for the quarter. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q2 2025 earnings at $1.32 EPS, Q3 2025 earnings at $1.33 EPS and Q4 2025 earnings at $1.46 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. During the same period last year, the firm posted $1.31 EPS. Henry Schein’s quarterly revenue was up .0% on a year-over-year basis.

Several other research firms also recently weighed in on HSIC. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. dropped their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Piper Sandler reissued an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. Finally, UBS Group reduced their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein presently has an average rating of “Hold” and an average price target of $77.50.

Henry Schein Trading Down 0.1 %

Shares of HSIC stock opened at $71.67 on Wednesday. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. The firm has a market capitalization of $9.18 billion, a PE ratio of 24.21, a P/E/G ratio of 1.98 and a beta of 0.86. The business’s fifty day moving average price is $70.26 and its 200 day moving average price is $69.90.

Insider Activity at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.14% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors have recently made changes to their positions in HSIC. Summit Securities Group LLC bought a new position in shares of Henry Schein during the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the 2nd quarter worth $37,000. Blue Trust Inc. increased its position in Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares during the period. Mather Group LLC. lifted its stake in Henry Schein by 16.8% in the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after buying an additional 216 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in shares of Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.